SciELO - Scientific Electronic Library Online

 
vol.28 número4Changing Paradigms in PsychiatrySCHIZOPHRENIA, SENSE AND NONSENSE índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Psiquiatría

versão impressa ISSN 0034-7450

Resumo

LEON, Javier et al. SERTRALINE IN OBSESSIVE COMPULSIVE DISORDER. AN OPEN, MULTICENTRIC, NON-COMPARATIVE STUDY. rev.colomb.psiquiatr. [online]. 1999, vol.28, n.4, pp.323-333. ISSN 0034-7450.

In order to evalúate the efficacy and safety of a fixed dose of Sertraline in the management of outpatients with Obsessive-Compulsive Disorder (OCD) with or without Major Depression comorbidity, an open, multicenter, non comparative study was conducted. Six Colombian centers included 52 Hispanic subjects, between 18 and 65 years old, mainly females (65%). The period of treatment was 16 to 32 weeks with 50 or 200 mg fixed dose. The subjects responded in similar proportion to the Sertraline treatment for OCD with or without Major Depression comorbidity. In the 52 initial subjects with 50 mg fixed dose, Y-BOCS scale improvedin average, 44% at 8a week, and, 63% at 16a week (p<0.001). GCI severity, GCI improvement and HAM-D followed the same tendency (p <0.001). Eightsubjects underwentan increase ofthe daily dose up to 200 mg. Twenty-one subjects reportad adverse events, headache (15%) and nausea (12%) were the most common. In conclusión, fixed dose of 50 mg of Sertraline was effective for improving the OCD in the majority of subjects (85%), 200 mg was also effective. Sertraline was well tolerated and the safety was similar as other studies.

Palavras-chave : Obsessive-Compulsive-Disorder; Sertraline; Depression; Y-BOCS; Colombia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons